Drug

Rydapt

36 flagged reaction(s) · 1,237 total co-reports · max PRR 40.2

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Bone Marrow Failure	76	40.2	41.8	signal
2	Leukaemia	27	31.0	31.4	signal
3	Cytopenia	28	25.3	25.7	signal
4	Acute Myeloid Leukaemia	30	20.8	21.1	signal
5	Lymphadenopathy	60	18.3	18.9	signal
6	Pancytopenia	93	18.0	18.9	signal
7	Myocarditis	17	16.2	16.4	signal
8	Hyperbilirubinaemia	15	15.7	15.8	signal
9	Myelosuppression	48	15.2	15.6	signal
10	Posterior Reversible Encephalopathy Syndrome	13	14.8	14.8	signal
11	Ejection Fraction Decreased	21	14.6	14.7	signal
12	Febrile Neutropenia	78	12.7	13.2	signal
13	Hepatic Cytolysis	14	12.4	12.5	signal
14	Bacteraemia	11	10.1	10.1	signal
15	Product Use Complaint	12	8.4	8.4	signal
16	Drug Intolerance	73	8.2	8.5	signal
17	Mucosal Inflammation	18	7.5	7.5	signal
18	Decreased Immune Responsiveness	6	6.6	6.6	signal
19	Agranulocytosis	11	6.4	6.5	signal
20	Electrocardiogram Qt Prolonged	20	6.0	6.1	signal
21	Septic Shock	24	6.0	6.1	signal
22	Hepatotoxicity	12	5.8	5.9	signal
23	Platelet Count Decreased	57	5.8	5.9	signal
24	Pericardial Effusion	12	5.6	5.7	signal
25	Malignant Neoplasm Progression	53	5.6	5.7	signal
26	Myelodysplastic Syndrome	7	5.2	5.2	signal
27	Cholestasis	9	5.1	5.1	signal
28	Blood Count Abnormal	7	4.9	4.9	signal
29	Full Blood Count Decreased	9	4.8	4.8	signal
30	Pneumonitis	12	4.8	4.8	signal
31	Toxic Skin Eruption	4	4.3	4.3	signal
32	Product Odour Abnormal	4	4.2	4.2	signal
33	Death	327	4.1	4.7	signal
34	Neoplasm Progression	11	3.4	3.4	signal
35	Pneumocystis Jirovecii Pneumonia	3	3.2	3.2	no signal
36	Therapy Cessation	15	3.2	3.2	signal